Four-phase product pipeline strategy driving innovation across Africa
Focus: High-demand biologics & Vaccines
Key Assets:
Focus: Next-gen therapies with higher accessibility
Key Assets:
Focus: Shared risk, accelerated tech transfer
Key Assets:
Focus: Breakthrough platforms
Key Assets:
Leveraging the power of the mRNA and Peptide platforms, we are addressing Africa's most pressing health challenges: from Diabetes to Infectious Diseases.